Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

Clinical trial NCT04338022 · TERMINATED

Trial details

NCT number: NCT04338022
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2020-06-12
Primary completion: 2023-10-02
Enrollment: 1124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.